Topics in Anti-Cancer Research

Volume: 3

Indexed in: Book Citation Index, Science Edition (BKCI-S), Chemical Abstracts, BIOSIS Previews, EBSCO, Ulrich's Periodicals Directory.

This is the third volume of the Patent eBook Series entitled Topics in Anti-Cancer Research. This eBook comprises updated reviews on topics relevant to modern cancer research published in the journal ...
[view complete introduction]

US $

*(Excluding Mailing and Handling)

Therapeutic Strategies Targeting Glioblastoma Stem Cells

Pp. 151-178 (28)

Estefania Carrasco-Garcia, Nicolas Sampron, Paula Aldaz, Olatz Arrizabalaga, Jorge Villanua, Cristina Barrena, Irune Ruiz, Mariano Arrazola, Charles Lawrie and Ander Matheu


Glioblastoma is the most common, aggressive and lethal brain tumor in adults. However, current therapeutic protocols have low success rates, and average overall survival is less than 15 months. The resistance to therapy is largely a result of the remarkable cellular and phenotypical heterogeneity that characterizes this type of tumor. The discovery of a subpopulation of cells exhibiting stem cell properties within the tumor bulk has profound implications for therapy as increasing evidence indicates that these cells, glioblastoma stem cells (GSCs), are responsible for the origin, maintenance and recurrence of the glioblastomas. These findings highlight the need to characterize GSCs in order to find novel treatments directly targeted specifically against them. In this chapter, we summarize the current knowledge regarding this issue, including some recent and relevant patents.


Antiangiogenic therapy, cancer stem cell, chemoresistance, differentiation therapy, glioblastoma multiforme, glioblastoma stem cell, glioma, metastasis, molecular target, neural stem cell, neurogenesis, patent, radioresistance, radiosensitizing therapy, stem marker, tumorigenicity, tumor recurrence, virotherapy, temozolomide.


Biodonostia Institute, Paseo Dr. Beguiristain s/n, E-20014 San Sebastian, Spain.